[{"Assets_0_Q1_USD":8514149.0,"CommonStockSharesOutstanding_0_Q1_shares":9937608.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-2534151.0,"NetIncomeLoss_1_Q1_USD":-3669494.0,"StockholdersEquity_0_Q1_USD":5977286.0,"Ticker":"RLMD","CIK":"1553643","name":"RELMADA THERAPEUTICS, INC.","OfficialName":"Relmada Therapeutics Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"772606380.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191113"}]